Cordis Corp. introduced the REGATTA Steerable Guidewire family of devices in the U.S. this week, which 12 selections of the REGATTA Steerable Guidewire and two choices of the REGATTA SB Steerable Guidewire. In April, the company plans to add the REGATTA HS Steerable Guidewire in two selections. The company says the line offers tailored solutions for the placement of catheters and other interventional devices in coronary arteries. The REGATTA Guidewires are all-purpose guidewires; the REGATTA SB Guidewires are designed to facilitate access to side branches; and the REGATTA HS Guidewires include features that ease placement in highly narrowed arteries. The three wires types are differentiated by variations in tip type, tip profile, lateral support and/or wire length. All versions of the wires feature a next-generation hydrophilic coating technology that prevents swelling and a single-piece steel core wire that enhances torque. In addition, the REGATTA Guidewires and the REGATTA HS Guidewires offer a unique microridge design for additional torque control. "When I tested the REGATTA Guidewire family, I was pleased to see each of them perform well under challenging circumstances," said Emerson C. Perin, M.D., Ph.D., F.A.C.C., director, New Interventional Cardiovascular Technology, Texas Heart Institute at St. Luke's Episcopal Hospital in Houston, Texas. "It is good to see Cordis back in the cath lab with a strong and innovative line of steerable guidewires."
If you enjoy this content, please share it with a colleague
ACC: Guide Wires Offer Physicians Many Steerable Choices
Related Content
May 21, 2025 – Johnson & Johnson MedTech has announced the U.S. launch of the Soundstar Crystal Ultrasound Catheter for ...
April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are ...
December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...
According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...
May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end ...
February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...
October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...
August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...
May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...